INJECTIVE ($INJ ) CEO MEETS WHITE HOUSE, SEC & CFTC | IS $INJ READY FOR A MASSIVE BREAKOUT?
Injective is pushing deeper into institutional finance as CEO Eric Chen reportedly meets U.S. officials to discuss compliant onchain markets and tokenized real-world assets (RWA).
KEY BULLISH CATALYSTS:
✅ SEC Transfer-Agent Registration Effective
✅ 135 Tokenized Asset Markets Reported
✅ CFTC-Regulated INJ Futures
✅ Thailand’s GULF Group Launches Injective Validator
✅ Monthly INJ Buybacks & Burns
MARKET MOMENTUM: INJ surged approximately 32% in 2 days.
Regulatory engagement, RWA tokenization, and institutional adoption could strengthen Injective’s long-term narrative. However, meetings do not equal government endorsement, and bullish catalysts never guarantee price appreciation.
Is $INJ entering its next major growth phase?
Injective is pushing deeper into institutional finance as CEO Eric Chen reportedly meets U.S. officials to discuss compliant onchain markets and tokenized real-world assets (RWA).
KEY BULLISH CATALYSTS:
✅ SEC Transfer-Agent Registration Effective
✅ 135 Tokenized Asset Markets Reported
✅ CFTC-Regulated INJ Futures
✅ Thailand’s GULF Group Launches Injective Validator
✅ Monthly INJ Buybacks & Burns
MARKET MOMENTUM: INJ surged approximately 32% in 2 days.
Regulatory engagement, RWA tokenization, and institutional adoption could strengthen Injective’s long-term narrative. However, meetings do not equal government endorsement, and bullish catalysts never guarantee price appreciation.
Is $INJ entering its next major growth phase?